Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
CDC Advances Data Strategy to Speed Public Health Response
The newest iteration of CDC's public health data strategy focuses on reducing burden and increasing efficiency.
4m read -
Data Modernization for Federal Health Enterprise
Technology and modernized data systems are opening up new frontiers for health care clinicians, agencies and patients.
37m watch -
Advancing Cybersecurity with ICAM
Security leaders are developing robust identity management strategies as agencies and organizations bolster zero-trust architectures.
10m read -
Leveraging Data for DHS Operational Efficiency
Officials share insights on data integration, AI and trustworthiness in immigration operations.
12m watch
